Table of contents

Extended reports

• Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus (6 December, 2007)

  M Nikpour, A A Dempsey, M B Urowitz, D D Gladman, D A Barnes
• CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus

  (30 October, 2007)

  M Mamtani, B Rovin, R Brey, J F Camargo, H Kulkarni, M Herrera, P Correa, S Holliday, J-M Anaya, S K Ahuja
• Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial (17 December, 2007)

  H K Genant, C G Peterfy, R Westhovens, J-C Becker, R Aranda, G Vratsanos, J Teng, J M Kremer
• Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study (23 November, 2007)

  G A W Bruyn, G Tate, F Caeiro, J Maldonado-Cocco, R Westhovens, H Tannenbaum, M Bell, O Forre, O Bjorneboe, P P Tak, K H Abeywickrama, P Bernhardt, P L C van Riel, for the RADD study group
• Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate (29 November, 2007)

  M Schiff, M Keiserman, C Codding, S Songcharoen, A Berman, S Nayiager, C Saldate, T Li, R Aranda, J-C Becker, C Lin, P L N Cornet, M Dougados
• Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial (31 July, 2007)

  P L C M van Riel, B Freundlich, D MacPeek, R Pedersen, J R Foehl, A Singh, on behalf of ADORE study investigators
• Genetic variations in the serotonin 5-HT2_A receptor gene (HTR2A) are associated with rheumatoid arthritis

  (15 November, 2007)

  A Kling, M Seddighzadeh, L Ärlestig, L Alfredsson, S Rantapää-Dahlqvist, L Padyukov
• Can ultrasonography improve on radiographic assessment in osteoarthritis of the hands? A comparison between radiographic and ultrasonographic detected pathology (23 November, 2007)

  H I Keen, R J Wakefield, A J Grainger, E M A Hensor, P Emery, P G Conaghan
• Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension (20 November, 2007)

  F Iannone, M T Riccardi, S Guiducci, R Bizzoca, M Cinelli, M Matucci-Cerinic, G Lapadula
• Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis (27 October, 2007)

  B J Radovits, J Fransen, P L C M van Riel, R F J M Laan
• B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor α antagonists: differential effects between good and poor clinical responders (29 October, 2007)

  D T La, C E Collins, H-T Yang, T-S Migone, W Stohl
• The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium (29 November, 2007)

  C A Wijbrandts, M G W Dijkgraaf, M C Kraan, M Vinkenoog, T J Smeets, H Dinant, K Vos, W F Lems, G J Wolbink, D Sijpkens, B A C Dijkmans, P P Tak
• Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients (2 November, 2007)

  V Gerloni, I Pontikaki, M Gattinara, F Fantini
• Efficient management of rheumatoid arthritis significantly reduces long-term functional disability (30 October, 2007)

  E Tanaka, A Mannalithara, E Inoue, M Hara, T Tomatsu, N Kamatani, G Singh, H Yamanaka
• A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis (26 October, 2007)

  S Magni-Manzoni, A Pistorio, E Labò, S Viola, P Garcia-Munitis, S Panigada, C Visconti, A Buoncompagni, A Martini, A Ravelli
• Innate production of tumour necrosis factor α and interleukin 10 is associated with radiological progression of knee osteoarthritis (20 November, 2007)

  S Botha-Scheepers, I Watt, E Slagboom, A J M de Craen, I Meulenbelt, F R Rosendaal, F C Breedveld, T W J Huizinga, M Kloppenburg